Barriers and supports for adapted physical activity in children and teens with IBD

Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases

Observational Fondation Lenval · NCT07383844

This project will ask children and teens (10–17) with Crohn's disease or ulcerative colitis about what helps or stops them from staying active to find ways to support regular physical activity.

Quick facts

Study typeObservational
Enrollment60 (estimated)
Ages10 Years to 17 Years
SexAll
SponsorFondation Lenval Academic / other
Locations1 site (Nice)
Trial IDNCT07383844 on ClinicalTrials.gov

What this trial studies

This observational study will enroll about 60 adolescents aged 10–17 with Crohn's disease or ulcerative colitis followed at Hôpital Lenval. Participants will complete two self-administered questionnaires (CAPAS-Q for activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview about experiences, obstacles, and supports for physical activity. Relevant clinical data including disease characteristics, treatment, and routine clinical parameters will be extracted from medical records to contextualize responses. Participation requires a single 45–60 minute visit during a routine hospital appointment with no additional intervention or follow-up.

Who should consider this trial

Good fit: Ideal participants are 10–17-year-olds with a confirmed diagnosis of Crohn's disease or ulcerative colitis for at least six months who are followed at Hôpital Lenval and can complete questionnaires and a one-on-one interview.

Not a fit: Those newly diagnosed (less than six months), with other chronic conditions or major cognitive or language barriers, or those seeking direct medical treatment changes are unlikely to receive direct benefit from participating.

Why it matters

Potential benefit: If successful, the findings could help design programs or clinical supports that make it easier for children and teens with IBD to be more active and improve quality of life.

How similar studies have performed: Prior questionnaire and interview studies in pediatric chronic illnesses, including some work in IBD, have successfully identified barriers to activity and helped guide intervention design.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 10 to 17 years at inclusion.
* Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months.
* Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice).
* Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview.
* Affiliated to, or beneficiary of, a social security scheme.
* no parental objection to participation (non-opposition).

Exclusion Criteria:

* Younger than 10 years or older than 17 years.
* No IBD diagnosis, or IBD diagnosed less than 6 months ago.
* Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation.
* Major language or cognitive impairment preventing adequate understanding or interview participation.
* Not affiliated to, or not beneficiary of, a social security scheme.

Where this trial is running

Nice

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Inflammatory Bowel Disease (Crohn's DiseaseUlcerative Colitis)physical activity
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.